These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 692278)

  • 1. Subcellular localization of dopamine-sensitive adenylate cyclase and dopamine receptor binding activities.
    Clement-Courmier Y; George R
    Life Sci; 1978 Aug; 23(6):539-43. PubMed ID: 692278
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple dopamine binding sites: subcellular localization and biochemical characterization.
    Clement-Cormier YC; George RJ
    J Neurochem; 1979 Mar; 32(3):1061-9. PubMed ID: 430039
    [No Abstract]   [Full Text] [Related]  

  • 3. Dopamine receptors and dopamine-sensitive adenylate cyclase in canine caudate nucleus. Characterization and solubilization.
    Sano K; Noshiro O; Katsuda K; Nishikori K; Maeno H
    Biochem Pharmacol; 1979 Dec; 28(24):3617-27. PubMed ID: 533562
    [No Abstract]   [Full Text] [Related]  

  • 4. 3H-Apomorphine interactions with dopamine receptors in calf brain.
    Thal L; Creese I; Snyder SH
    Eur J Pharmacol; 1978 Jun; 49(3):295-9. PubMed ID: 658143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential distribution of opiate and neuroleptic receptors and dopamine-sensitive adenylate cyclase in rat brain.
    Leysen J; Laduron P
    Life Sci; 1977 Jan; 20(2):281-8. PubMed ID: 190508
    [No Abstract]   [Full Text] [Related]  

  • 6. Direct evidence for presynaptic and postsynaptic dopamine receptors in brain.
    Nagy JI; Lee T; Seeman P; Fibiger HC
    Nature; 1978 Jul; 274(5668):278-81. PubMed ID: 683308
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopamine receptors, neuroleptics, and schizophrenia.
    Snyder SH
    Am J Psychiatry; 1981 Apr; 138(4):460-4. PubMed ID: 6111227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3H-Spiroperidol binding and dopamine-stimulated adenylate cyclase: evidence for multiple classes of receptors in primate brain regions.
    Thal LJ; Makman MH; Ahn HS; Mishra RK; Horowitz SG; Dvorkin B; Katzman R
    Life Sci; 1978 Aug; 23(6):629-33. PubMed ID: 99609
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of some derivatives of 2-aminotetralin on dopamine-sensitive adenylate cyclase and on the binding of (3H)haloperidol to neuroleptic receptors in the rat striatum.
    Cannon JG; Costall B; Laduron PM; Leysen JE; Naylor RJ
    Biochem Pharmacol; 1978 May; 27(10):1417-20. PubMed ID: 567987
    [No Abstract]   [Full Text] [Related]  

  • 10. Dopamine- and apomorphine-sensitive adenylate cyclase in homogenates of rabbit retina.
    Bucher MB; Schorderet M
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 288(1):103-7. PubMed ID: 169480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of 3H-apomorphine binding by dopamine and bromocriptine.
    Robertson HA
    Eur J Pharmacol; 1980 Jan; 61(2):209-11. PubMed ID: 7353592
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of seizures kindled by subconvulsant doses of pentylenetetrazol on dopamine receptor binding and dopamine-sensitive adenylate cyclase in the rat.
    Gee KW; Hollinger MA; Killam EK
    Exp Neurol; 1981 Oct; 74(1):265-75. PubMed ID: 6269870
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs.
    Jenner P; Elliott PN; Clow A; Reavill C; Marsden CD
    J Pharm Pharmacol; 1978 Jan; 30(1):46-8. PubMed ID: 22724
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of neuroleptics on 3H-haloperidol and 3H-cis(Z)-flupenthixol binding and on adenylate cyclase activity in vitro.
    Hyttel J
    Life Sci; 1978 Aug; 23(6):551-5. PubMed ID: 29194
    [No Abstract]   [Full Text] [Related]  

  • 15. Cortical tubular and glomerular dopamine receptors in the rat kidney.
    Felder RA; Blecher M; Eisner GM; Jose PA
    Am J Physiol; 1984 May; 246(5 Pt 2):F557-68. PubMed ID: 6720961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aporphines. 39. Synthesis, dopamine receptor binding, and pharmacological activity of (R)-(-)- and (S)-(+)-2-hydroxyapomorphine.
    Neumeyer JL; Arana GW; Ram VJ; Kula NS; Baldessarini RJ
    J Med Chem; 1982 Aug; 25(8):990-2. PubMed ID: 7120288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three classes of dopamine receptor (D-2, D-3, D-4) identified by binding studies with 3H-apomorphine and 3H-domperidone.
    Sokoloff P; Martres MP; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(2):89-102. PubMed ID: 7207647
    [No Abstract]   [Full Text] [Related]  

  • 18. Ontogenesis of dopamine receptor binding in the corpus striatum of the rat.
    Pardo JV; Creese I; Burt DR; Snyder SH
    Brain Res; 1977 Apr; 125(2):376-82. PubMed ID: 851885
    [No Abstract]   [Full Text] [Related]  

  • 19. 6- and 8-hydroxy-3,4-dihydro-3-(dipropylamino)-2H-1-benzopyrans. Dopamine agonists with autoreceptor selectivity.
    Wise LD; DeWald HA; Hawkins ES; Reynolds DM; Heffner TG; Meltzer LT; Pugsley TA
    J Med Chem; 1988 Mar; 31(3):688-91. PubMed ID: 3346882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine-sensitive adenylate cyclase in retina--subcellular distribution.
    Clement-Cormier YC; Redburn DA
    Biochem Pharmacol; 1978; 27(18):2281-2. PubMed ID: 728181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.